InvestorsHub Logo
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

Re: None

Wednesday, 12/14/2016 7:20:39 AM

Wednesday, December 14, 2016 7:20:39 AM

Post# of 465858
Should Anavex be worried about competition from BACE inhibitors, Aducanumab, and any other contenders that are out there? How much of an affect will they have on Anavex's profitability (assuming 273 gets approved for Alz)?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News